Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith M Boer

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Blood Advances|February 22, 2024
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutationsInge van Outersterp, Judith M Boer, Cesca van de Ven, et al.
Hemasphere|September 22, 2023
ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic LeukemiaInge van Outersterp, Vincent H J van der Velden, Patricia G Hoogeveen, et al.
Cephalalgia : an International Journal of Headache|August 30, 2013
RNA expression profiling in brains of familial hemiplegic migraine type 1 knock-in miceBoukje de Vries, Else Eising, Ludo A M Broos, et al.
Plos Pathogens|May 30, 2013
Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune responseRezaul Karim, Bart Tummers, Craig Meyers, et al.
Hemasphere|July 16, 2024
Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experienceJudith M Boer, Uri Ilan, Aurélie Boeree, et al.
European Journal of Human Genetics : EJHG|December 15, 2010
Tumour-specific methylation of PTPRG intron 1 locus in sporadic and Lynch syndrome colorectal cancerEddy H J van Roon, Noël F C C de Miranda, Merlijn P van Nieuwenhuizen, et al.
BMC Genomics|March 12, 2008
Can subtle changes in gene expression be consistently detected with different microarray platforms?Paola Pedotti, Peter A C 't Hoen, Erno Vreugdenhil, et al.
JCO Precision Oncology|February 28, 2025
Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics: A Nationwide Prospective Comparison in Children With ALLJudith M Boer, Marco J Koudijs, Lennart A Kester, et al.
Hemasphere|May 8, 2023
The Prognostic Effect of <i>IKZF1</i> Deletions in <i>ETV6</i>::<i>RUNX1</i> and High Hyperdiploid Childhood Acute Lymphoblastic LeukemiaAnna Østergaard, Amir Enshaei, Rob Pieters, et al.
Leukemia|July 4, 2024
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of inductionAnthony V Moorman, Amir Enshaei, Daniel Murdy, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Blood Advances|February 22, 2024
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutationsInge van Outersterp, Judith M Boer, Cesca van de Ven, et al.
Hemasphere|September 22, 2023
ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic LeukemiaInge van Outersterp, Vincent H J van der Velden, Patricia G Hoogeveen, et al.
Cephalalgia : an International Journal of Headache|August 30, 2013
RNA expression profiling in brains of familial hemiplegic migraine type 1 knock-in miceBoukje de Vries, Else Eising, Ludo A M Broos, et al.
Plos Pathogens|May 30, 2013
Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune responseRezaul Karim, Bart Tummers, Craig Meyers, et al.
Hemasphere|July 16, 2024
Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experienceJudith M Boer, Uri Ilan, Aurélie Boeree, et al.
European Journal of Human Genetics : EJHG|December 15, 2010
Tumour-specific methylation of PTPRG intron 1 locus in sporadic and Lynch syndrome colorectal cancerEddy H J van Roon, Noël F C C de Miranda, Merlijn P van Nieuwenhuizen, et al.
BMC Genomics|March 12, 2008
Can subtle changes in gene expression be consistently detected with different microarray platforms?Paola Pedotti, Peter A C 't Hoen, Erno Vreugdenhil, et al.
JCO Precision Oncology|February 28, 2025
Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics: A Nationwide Prospective Comparison in Children With ALLJudith M Boer, Marco J Koudijs, Lennart A Kester, et al.
Hemasphere|May 8, 2023
The Prognostic Effect of <i>IKZF1</i> Deletions in <i>ETV6</i>::<i>RUNX1</i> and High Hyperdiploid Childhood Acute Lymphoblastic LeukemiaAnna Østergaard, Amir Enshaei, Rob Pieters, et al.
Leukemia|July 4, 2024
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of inductionAnthony V Moorman, Amir Enshaei, Daniel Murdy, et al.
Pageof 10